“PerkinElmer, a global leader in human and environmental health and an innovator
in the field of prenatal screening for more than thirty years, announced today
the first available early onset preeclampsia screening test in the United
States. The PreeclampsiaScreen(TM) | T1 serum screening test enables physicians
to more precisely detect asymptomatic patients in the first trimester of
pregnancy who are at high risk for developing the dangerous condition, allowing
for earlier identification, management and intervention. Early onset
preeclampsia is a potentially serious condition that affects 0.5% of all
pregnancies, often contributing more to the pregnant mother’s and baby’s risks
of morbidity and mortality than does the late form of the disorder.”
Find the full article here.
demilade christian 
Recent Comments